BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30821676)

  • 1. Updates on
    Grace E; Chahine EB
    Sr Care Pharm; 2019 Jan; 34(1):29-42. PubMed ID: 30821676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile Infection in Older Adults: Systematic Review of Efforts to Reduce Occurrence and Improve Outcomes.
    Marshall LL; Peasah S; Stevens GA
    Consult Pharm; 2017 Jan; 32(1):24-41. PubMed ID: 28077203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversies in the Prevention and Treatment of
    Bainum TB; Reveles KR; Hall RG; Cornell K; Alvarez CA
    Microorganisms; 2023 Feb; 11(2):. PubMed ID: 36838352
    [No Abstract]   [Full Text] [Related]  

  • 4. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update of treatment algorithms for Clostridium difficile infection.
    Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
    Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Individualized treatment strategies for Clostridium difficile infections].
    Solbach P; Dersch P; Bachmann O
    Internist (Berl); 2017 Jul; 58(7):675-681. PubMed ID: 28589214
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Asempa TE; Nicolau DP
    Clin Interv Aging; 2017; 12():1799-1809. PubMed ID: 29123385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of
    Deac IŞ; Ofrim AM; Fărcaş RA; Grad S; Popa ŞL; Dumitraşcu DL
    Med Pharm Rep; 2024 Jan; 97(1):5-11. PubMed ID: 38344334
    [No Abstract]   [Full Text] [Related]  

  • 9. Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.
    Mizusawa M; Doron S; Gorbach S
    Drugs Aging; 2015 Aug; 32(8):639-47. PubMed ID: 26233437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of Clostridium difficile infection.
    Dupont HL
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of
    Saha S; Khanna S
    Therap Adv Gastroenterol; 2019; 12():1756284819847651. PubMed ID: 31105766
    [No Abstract]   [Full Text] [Related]  

  • 12. Updated Management Guidelines for
    Gnocchi M; Gagliardi M; Gismondi P; Gaiani F; De' Angelis GL; Esposito S
    Pathogens; 2020 Apr; 9(4):. PubMed ID: 32316346
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clostridium difficile infection (CDI) in the course of time - an issue only for the internist?].
    Weis S; John E; Lippmann N; Mössner J; Lübbert C
    Zentralbl Chir; 2014 Aug; 139(4):460-8. PubMed ID: 24132675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?
    Cornely OA
    Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():28-35. PubMed ID: 23121552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fidaxomicin for the treatment of Clostridium difficile infections.
    Whitman CB; Czosnowski QA
    Ann Pharmacother; 2012 Feb; 46(2):219-28. PubMed ID: 22318930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan.
    Mikamo H; Tateda K; Yanagihara K; Kusachi S; Takesue Y; Miki T; Oizumi Y; Gamo K; Hashimoto A; Toyoshima J; Kato K
    J Infect Chemother; 2018 Sep; 24(9):744-752. PubMed ID: 29934056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for
    Dubberke ER; Puckett JT; Obi EN; Kamal-Bahl S; Desai K; Stuart B; Doshi JA
    Open Forum Infect Dis; 2022 Oct; 9(10):ofac435. PubMed ID: 36267250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections.
    Lancaster JW; Matthews SJ
    Clin Ther; 2012 Jan; 34(1):1-13. PubMed ID: 22284993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
    Manthey CF; Eckmann L; Fuhrmann V
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1239-1250. PubMed ID: 28766951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile infection: A brief update on emerging therapies.
    Goldberg EJ; Bhalodia S; Jacob S; Patel H; Trinh KV; Varghese B; Yang J; Young SR; Raffa RB
    Am J Health Syst Pharm; 2015 Jun; 72(12):1007-12. PubMed ID: 26025991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.